Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events
A completed clinical trial update on preventing cardiovascular events in patients with high to very high risk dyslipidemia; results posted i…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR [Phase 2]
Phase 2 trial comparing extended-release K-877-ER to immediate-release K-877-IR in dyslipidemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Suvaro®OD Tablet in patients with dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin [Phase 3]
Phase 3 trial update evaluating efficacy and safety of valsartan alone and in combination with simvastatin for hypertension and hypercholest…
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Look AHEAD: Action for Health in Diabetes [NA]
Clinical trial update for Look AHEAD study (diabetes and cardiovascular risk factors) with completed status and results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of DW1125 and DW1125A for hypercholesterolemia and dyslipidemia has been complet…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) [Phase 3]
Phase 3 trial update for metformin/atorvastatin combination therapy in adults with Type 2 diabetes and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension [Phase 3]
Open-label Phase 3 extension evaluating cardiovascular outcomes with PCSK9 inhibition in adults at elevated risk with dyslipidemia; study co…
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries [Phase 3]
Amgen's Fourier open-label extension study in adults with clinically evident cardiovascular disease and dyslipidemia was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: A Study of AZD8233 in Participants With Dyslipidemia [Phase 2]
Phase 2 clinical trial of AZD8233 in participants with dyslipidemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol [Phase 1, Phase 2]
Phase 1/2 safety and pharmacokinetic study of RVX000222 in healthy subjects and individuals with low HDL cholesterol completed.
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia [Phase 3]
Clinical trial update for Berlim 25/10 in Type 2 Diabetes Mellitus and Dyslipidemia (Phase 3) with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP. [Phase 3]
Phase 3 trial evaluating the efficacy and safety of a fixed-dose combination of atorvastatin and fenofibrate versus atorvastatin alone in pa…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 [Phase 3]
Phase 3 clinical trial evaluating CKD-386 for efficacy and safety in patients with dyslipidemia and hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension [Phase 4]
Phase 4 trial evaluating Duowell® versus telmisartan monotherapy in patients with mild dyslipidemia and hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides [Phase 2]
Phase 2 trial update for ETC-1002 evaluating efficacy and safety in dyslipidemia with variable triglyceride levels; results posted after com…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets [Phase 4]
Phase 4 clinical trial evaluating benefits of starting at various atorvastatin doses to achieve cholesterol targets.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients. [Phase 4]
Phase 4 trial evaluating the COACH program for management of dyslipidemia; study completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) [Phase 4]
Phase 4 trial evaluating different starting doses of atorvastatin to achieve cholesterol targets.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia [Phase 3]
Open-label phase 3 trial evaluating the combination of amlodipine and atorvastatin in subjects with hypertension and dyslipidemia has comple…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population [Phase 4]
Phase 4 trial update evaluating Caduet's ability to achieve blood pressure and lipid endpoints in adults with hypertension and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Caduet in an Untreated Subject Population [Phase 4]
Phase 4 trial update for Caduet in untreated subjects showing completed status.
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia [Phase 3]
Phase 3 trial assessing safety, tolerability, and LDL-C reduction with evolocumab in HIV patients with hyperlipidemia/mixed dyslipidemia; co…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: 12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia [Phase 2, Phase 3]
12-month open-label extension study of LCP-AtorFen in dyslipidemia completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia [Phase 2]
Phase 2 trial assessing an atorvastatin/fenofibrate combination (LCP-AtorFen) for dyslipidemia has completed with results posted.